Metribuzin-induced non-adverse liver changes result in rodent-specific non-adverse thyroid effects via uridine 5′-diphospho-glucuronosyltransferase (UDPGT, UGT) modulation

Title
Metribuzin-induced non-adverse liver changes result in rodent-specific non-adverse thyroid effects via uridine 5′-diphospho-glucuronosyltransferase (UDPGT, UGT) modulation
Authors
Keywords
Metribuzin, Thyroid, Mode of action (MOA), UDPGT, IPCS, Human relevance, NOAEL, Endocrine disruption
Journal
REGULATORY TOXICOLOGY AND PHARMACOLOGY
Volume 122, Issue -, Pages 104884
Publisher
Elsevier BV
Online
2021-02-16
DOI
10.1016/j.yrtph.2021.104884

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now